Estimation of Excess Mortality and Years of Life Lost to COVID-19 in Norway and Sweden between March and November 2020.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
08 04 2021
Historique:
received: 16 03 2021
revised: 03 04 2021
accepted: 05 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 6 5 2021
Statut: epublish

Résumé

We estimate the weekly excess all-cause mortality in Norway and Sweden, the years of life lost (YLL) attributed to COVID-19 in Sweden, and the significance of mortality displacement. We computed the expected mortality by taking into account the declining trend and the seasonality in mortality in the two countries over the past 20 years. From the excess mortality in Sweden in 2019/20, we estimated the YLL attributed to COVID-19 using the life expectancy in different age groups. We adjusted this estimate for possible displacement using an auto-regressive model for the year-to-year variations in excess mortality. We found that excess all-cause mortality over the epidemic year, July 2019 to July 2020, was 517 (95%CI = (12, 1074)) in Norway and 4329 [3331, 5325] in Sweden. There were 255 COVID-19 related deaths reported in Norway, and 5741 in Sweden, that year. During the epidemic period of 11 March-11 November, there were 6247 reported COVID-19 deaths and 5517 (4701, 6330) excess deaths in Sweden. We estimated that the number of YLL attributed to COVID-19 in Sweden was 45,850 [13,915, 80,276] without adjusting for mortality displacement and 43,073 (12,160, 85,451) after adjusting for the displacement accounted for by the auto-regressive model. In conclusion, we find good agreement between officially recorded COVID-19 related deaths and all-cause excess deaths in both countries during the first epidemic wave and no significant mortality displacement that can explain those deaths.

Identifiants

pubmed: 33917872
pii: ijerph18083913
doi: 10.3390/ijerph18083913
pmc: PMC8068261
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Nature. 2020 Apr;580(7805):574
pubmed: 32317784
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Age Ageing. 1996 Sep;25(5):343-8
pubmed: 8921136
Lancet Public Health. 2021 Jan;6(1):e9
pubmed: 33301723
J Korean Med Sci. 2020 Aug 17;35(32):e300
pubmed: 32808515
Proc Biol Sci. 2020 Aug 12;287(1932):20201405
pubmed: 32781946
Nat Commun. 2020 Nov 11;11(1):5710
pubmed: 33177507
Phys Rev Lett. 1996 Jul 22;77(4):635-638
pubmed: 10062864
Int J Public Health. 2020 Dec;65(9):1525-1527
pubmed: 32857238
Clin Infect Dis. 2020 Dec 15;71(12):3174-3181
pubmed: 32609825

Auteurs

Martin Rypdal (M)

Department of Mathematics and Statistics, UiT-The Arctic University of Norway, 9019 Tromsø, Norway.

Kristoffer Rypdal (K)

Department of Mathematics and Statistics, UiT-The Arctic University of Norway, 9019 Tromsø, Norway.

Ola Løvsletten (O)

Department of Community Medicine, UiT-The Arctic University of Norway, 9019 Tromsø, Norway.

Sigrunn Holbek Sørbye (SH)

Department of Mathematics and Statistics, UiT-The Arctic University of Norway, 9019 Tromsø, Norway.

Elinor Ytterstad (E)

Department of Mathematics and Statistics, UiT-The Arctic University of Norway, 9019 Tromsø, Norway.

Filippo Maria Bianchi (FM)

Department of Mathematics and Statistics, UiT-The Arctic University of Norway, 9019 Tromsø, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH